{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:04:46Z","timestamp":1761541486292,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.brachy.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T20:08:20Z","timestamp":1555531700000},"page":"453-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?"],"prefix":"10.1016","volume":"18","author":[{"given":"Bryan J.","family":"Ager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samual R.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia A.","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Jessica","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Soisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark K.","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa L.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Sause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2019.03.001_bib1","first-page":"7","article-title":"Cancer Statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"unstructured":"National Comprehensive Cancer Network. Endometrial Cancer (Version 1.2018).","key":"10.1016\/j.brachy.2019.03.001_bib2"},{"key":"10.1016\/j.brachy.2019.03.001_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2019.03.001_bib4","first-page":"1707","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natlcancer Inst"},{"key":"10.1016\/j.brachy.2019.03.001_bib5","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2019.03.001_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ijrobp.2005.03.007","article-title":"Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review","volume":"63","author":"Scholten","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib9","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2019.03.001_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2019.03.001_bib12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2019.03.001_bib13","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2019.03.001_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","article-title":"Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study","volume":"19","author":"Sorbe","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2019.03.001_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijgo.2014.06.022","article-title":"Contemporary analysis of pelvic and para-aortic metastasis in endometrial cancer using the SEER registry","volume":"127","author":"Katsoulakis","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.brachy.2019.03.001_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3802\/jgo.2015.26.1.32","article-title":"Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria","volume":"26","author":"Kong","year":"2015","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib18","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2015.62.5459","article-title":"Postoperative radiation therapy for endometrial cancer: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology evidence-based Guideline","volume":"33","author":"Meyer","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","article-title":"American Brachytherapy Task Group Report: adjuvant vaginal brachytherapy for early-stage endometrial cancer: a comprehensive review","volume":"16","author":"Harkenrider","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.03.001_bib20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ijrobp.2017.09.008","article-title":"A phase 3 trial of pelvic radiation therapy versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy in patients with high-risk, early-stage endometrial cancer: a Gynecology Oncology group study [abstract]","volume":"99","author":"Randall","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib21","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib22","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jnci\/djs374","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis","volume":"104","author":"Kong","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2019.03.001_bib23","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.03.001_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-8140(00)00171-7","article-title":"Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer","volume":"56","author":"Pearcey","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib26","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.12.079","article-title":"Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels","volume":"62","author":"Sorbe","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2012.07.111","article-title":"A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer","volume":"127","author":"Townamchai","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 Survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.03.001_bib29","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J","article-title":"Some comments on frequently used multiple endpoint adjustment methods in clinical trials","volume":"16","author":"Sankoh","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.brachy.2019.03.001_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0360-3016(90)90094-Z","article-title":"Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I","volume":"18","author":"Sorbe","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib31","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0360-3016(95)00097-I","article-title":"Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol","volume":"32","author":"Noyes","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib32","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0360-3016(98)00292-2","article-title":"High-dose-rate brachytherapy alone post-hysterectomy for endometrial cancer","volume":"42","author":"MacLeod","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/gyno.1998.5155","article-title":"Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy","volume":"71","author":"Weiss","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1999.5526","article-title":"Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy","volume":"75","author":"Chadha","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib35","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1525-1438.1999.99061.x","article-title":"Outpatient vaginal cuff brachytherapy for endometrial cancer","volume":"9","author":"Petereit","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2019.03.001_bib36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(99)00427-7","article-title":"High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer","volume":"46","author":"Anderson","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib37","first-page":"235","article-title":"Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma","volume":"99","author":"Horowitz","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2019.03.001_bib38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ygyno.2005.02.021","article-title":"Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer","volume":"97","author":"Jolly","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2004.09.054","article-title":"Intravaginal brachytherapy alone for intermediate-risk endometrial cancer","volume":"62","author":"Alektiar","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib40","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ijrobp.2005.01.026","article-title":"Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer","volume":"62","author":"Solhjem","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib41","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1525-1438.2008.01198.x","article-title":"Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery","volume":"18","author":"Atahan","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2019.03.001_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2009.06.027","article-title":"Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation","volume":"116","author":"McCloskey","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib43","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2018.04.049","article-title":"Multi-institutional analysis of vaginal brachytherapy alone for women with stage II endometrial carcinoma","volume":"101","author":"Harkenrider","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2019.03.001_bib44","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2017.08.005","article-title":"Disparities in care for elderly women with endometrial cancer adversely effects survival","volume":"147","author":"Torgeson","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2019.03.001_bib45","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/cncr.22997","article-title":"Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: a surveillance, epidemiology, and end results population study","volume":"110","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2019.03.001_bib46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.brachy.2015.03.001","article-title":"Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma","volume":"14","author":"Park","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2019.03.001_bib47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in Observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.brachy.2019.03.001_bib48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/aje\/kwq439","article-title":"Doubly robust estimation of causal effects","volume":"173","author":"Funk","year":"2011","journal-title":"Am J Epidemiol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118307645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118307645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:14:48Z","timestamp":1761531288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472118307645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1538472118307645"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2019.03.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}